Breaking News

Close

Novo Nordisk A/S (NVON)

	Symbol	Exchange	Currency
	NVO	NYSE	USD	Real-time
	NOVOBc	BATS Europe	DKK	Delayed
	0QIU	London	DKK	Real-time
	NVON	Mexico	MXN	Delayed
	NOVG	Dusseldorf	EUR	Delayed
	NOVG	Xetra	EUR	Delayed
	NOVG	Frankfurt	EUR	Delayed
	NOVOb	Copenhagen	DKK	Real-time
	NNO2	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

2,186.880 +17.510 +0.81%

15:59:58 - Closed. Currency in MXN ( Disclaimer )

Type: Equity

Market: Mexico

ISIN: US6701002056

Volume: 119
Bid/Ask: 2,170.020 / 2,235.990
Day's Range: 2,176.000 - 2,186.880

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

NVON Balance Sheet

Featured here, the Balance Sheet for Novo Nordisk A/S, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

Annual Quarterly

InvestingPro

Advanced Balance Sheet

Period Ending:

2023

31/12

2023

30/09

2023

30/06

2023

31/03

Total Current Assets

139646

142199

137551

113943

Cash and Short Term Investments	30230	47595	36408	27771
Cash	-	-	-	-
Cash & Equivalents	14392	30144	21574	14936
Short Term Investments	15838	17451	14834	12835
Total Receivables, Net	75261	61964	70521	57921
Accounts Receivables - Trade, Net	64770	52602	61294	50502
Total Inventory	31811	29534	28020	25615
Prepaid Expenses	-	-	-	-
Other Current Assets, Total	2344	3106	2602	2636

Total Assets

314486

300101

280753

250025

Property/Plant/Equipment, Total - Net	90961	81461	75024	70014
Property/Plant/Equipment, Total - Gross	138583	-	-	-
Accumulated Depreciation, Total	-47622	-	-	-
Goodwill, Net	4464	-	-	-
Intangibles, Net	60406	55726	50749	50489
Long Term Investments	1663	1471	1479	1211
Note Receivable - Long Term	10491	9362	9227	7419
Other Long Term Assets, Total	1430	430	338	288
Other Assets, Total	-9352	6941	-9453	-2755

Total Current Liabilities

169655

172552

156618

131961

Accounts Payable	25606	20106	17788	10050
Payable/Accrued	-	-	-	-
Accrued Expenses	99427	-	-	-
Notes Payable/Short Term Debt	456	6613	6289	1251
Current Port. of LT Debt/Capital Leases	6022	-	-	-
Other Current liabilities, Total	38144	145833	132541	120660

Total Liabilities

207925

207110

190280

170151

Total Long Term Debt	20528	19924	19415	24267
Long Term Debt	15976	19924	19415	24267
Capital Lease Obligations	4552	-	-	-
Deferred Income Tax	10162	7885	7627	7875
Minority Interest	-	-	-	-
Other Liabilities, Total	7124	136	331	4797

Total Equity

106561

92991

90473

79874

Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	451	451	451	456
Additional Paid-In Capital	-	-	-	-
Retained Earnings (Accumulated Deficit)	104839	91735	88118	77070
Treasury Stock - Common	-5	-5	-3	-6
ESOP Debt Guarantee	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-
Other Equity, Total	1276	810	1907	2354

Total Liabilities & Shareholders' Equity

314486

300101

280753

250025

Total Common Shares Outstanding

-

4476.9

4490.4

4499.2

Total Preferred Shares Outstanding

-

-

-

-

* In Millions of DKK (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

NVO Comments

Write your thoughts about Novo Nordisk A/S

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Grumpy Cat Apr 18, 2024 9:38AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

this company was doing so well, what happened.

0 0

Jackson Nahm Apr 18, 2024 9:38AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Profit taking imo, it’ll go higher

0 0

Keith Dunkelbarger Apr 17, 2024 6:27PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

A1C down from 9.4 to 6.2 and weight down from 254 to 238 with Ozempic. Lot of flatulence and air freshener.

0 0

yeongjin white Mar 14, 2024 11:38PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

300 by 2024

6 0

roy reyes Feb 05, 2024 8:07PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

gonna dominate the obesity space with Catalent mreger

2 0

Karsten Vester Feb 01, 2024 4:37AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

450 by 2030.. Serving 1 mill custumors now and there are 800 mill. U do the math..

7 0

D Petersen Jan 29, 2024 8:45PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

NVO should advance nicely Wednesday on good earnings and a bright 2024 outlook.

2 1

Karsten Vester Nov 28, 2023 9:52AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Eli is very keen on disrupting NN but they dont even have cardio vascular studies or a candidate for next generation but NN dos. They are way behind so dont be disrupted by their lobby activities ….

4 3

In the Money Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

140+ eoy

4 1

Paul Chan Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Not with the recent deaths from Ozempic.

0 3

Karsten Vester Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Come with dome documentstion dude. Far out to say

0 0

dar dar Oct 13, 2023 12:22PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

like all things, eventually we will know the outcome

0 2

Karsten Vester Oct 03, 2023 11:54AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Now all small investors seems to fanzy ophra Winfrey to dictate the benefits and dowfalls in pharma industry. What a world with celebraties and you tupers now rules the world. S… t.. f… up woman - you dont know what you are talking about and go back to girlish problems and your billions..

1 1

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="224458244">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="224458244" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="224458244" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="224458244">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="224458244">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="224458244" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="224458244" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="224458244">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,258.5	+172.7	+0.45%
	US 500	5,099.4	+51.0	+1.01%
	Dow Jones	38,239.66	+153.86	+0.40%
	S&P 500	5,099.96	+51.54	+1.02%
	Nasdaq	15,927.90	+316.14	+2.03%
	S&P 500 VIX	15.03	-0.34	-2.21%
	Dollar Index	105.945	+0.494	+0.47%

	Crude Oil WTI	83.66	+0.09	+0.11%
	Brent Oil	89.33	+0.32	+0.36%
	Natural Gas	1.925	-0.061	-3.07%
	Gold	2,348.80	+6.30	+0.27%
	Silver	27.212	-0.141	-0.52%
	Copper	4.5668	+0.0493	+1.09%
	US Soybeans	1,159.25	-3.50	-0.30%

	U.S. 10Y	4.665	-0.043	-0.91%
	U.S. 30Y	4.778	-0.043	-0.88%
	U.S. 5Y	4.685	-0.032	-0.67%
	U.S. 3M	5.411	+0.007	+0.14%
	US 10Y T-Note	107.59	+0.23	+0.22%
	Euro Bund	130.22	+0.44	+0.34%
	10-2 Yield Spread	-29.77	-1.26	4.42%

	Apple	169.30	-0.59	-0.35%
	Alphabet A	171.95	+15.95	+10.22%
	Tesla	168.29	-1.89	-1.11%
	Amazon.com	179.62	+5.95	+3.43%
	Netflix	561.23	-3.57	-0.63%
	Meta Platforms	443.29	+1.91	+0.43%
	Bank of America	37.82	-0.09	-0.24%

Recent Quotes

	Name	Price	Chg.	Chg. %
	NVON	2,186.880	+17.510	+0.81%

	Name	Last	Chg. %	Vol.
	TSLA	168.29	-1.11%	108.02M
	GOOGL	171.95	+10.22%	63.43M
	GOOG	173.69	+9.97%	54.39M
	NVDA	877.35	+6.18%	53.60M
	META	443.29	+0.43%	31.82M
	MSFT	406.32	+1.82%	28.45M
	BRKa	607,342	-0.69%	13.56K

	Name	Last	Chg. %	Vol.
	RMD	218.06	+18.89%	4.27M
	GOOGL	171.95	+10.22%	63.43M
	GOOG	173.69	+9.97%	54.39M
	SMCI	857.44	+8.90%	6.99M
	BALL	69.82	+6.68%	4.49M
	NVDA	877.35	+6.18%	53.60M
	DDOG	131.45	+4.95%	4.96M

	Name	Last	Chg. %	Vol.
	DXCM	124.34	-9.91%	8.51M
	TEAM	179.45	-9.56%	5.86M
	INTC	31.88	-9.20%	118.79M
	ODFL	182.42	-7.24%	3.42M
	FICO	1,109.40	-7.06%	433.77K
	AON	285.88	-6.58%	4.56M
	CINF	110.88	-6.38%	1.97M